Materias dentro de su búsqueda.
Mostrando 1,061 - 1,080 Resultados de 9,628 Para Buscar '"patentes"', tiempo de consulta: 0.17s Limitar resultados
  1. 1061
    “…ChEMU involves two key information extraction tasks over chemical reactions from patents. Task 1—Named entity recognition—involves identifying chemical compounds as well as their types in context, i.e., to assign the label of a chemical compound according to the role which the compound plays within a chemical reaction. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    ChEMU: Named Entity Recognition and Event Extraction of Chemical Reactions from Patents
  2. 1062
    “…This study aims to map patents and patent applications for innovator as well as biosimilar monoclonal antibodies in Europe, and investigates legal challenges associated with patenting the innovator product and alleged infringing activities, focusing on consequences for biosimilar developers. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    An overview of patents on therapeutic monoclonal antibodies in Europe: are they a hurdle to biosimilar market entry?
  3. 1063
    “…BACKGROUND: Traditional Chinese Patent Medicine (TCPM) is now being used more and more extensively for primary hypertension in China. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Traditional Chinese Patent Medicine for Primary Hypertension: A Bayesian Network Meta-Analysis
  4. 1064
    “…As an indispensable part of TCM, Chinese patent medicines (CPMs) are highly valued and critically acclaimed in their campaign to contain and tackle the epidemic, they can achieve considerable effects for both suspected cases under medical observation period, and confirmed individuals with serious underlying diseases or critical conditions. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence
  5. 1065
    “…Introduction: Percutaneous closure of patent foramen ovale (PFO) in selected patients with cryptogenic cerebrovascular ischemic events (CEs) decreases the risk of recurrent stroke; however, optimal patient selection criteria are still under investigation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Epidemiology of Patent Foramen Ovale in General Population and in Stroke Patients: A Narrative Review
  6. 1066
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Serial Shunt Evaluation Reveals Limitations of Contemporary Screening Studies for Patent Foramen Ovale
  7. 1067
    “…Patent foramen ovale (PFO) is an anatomical communication between the left and the right atrium due to the lack of completed sealing of the fossa ovalis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cryptogenic stroke over 60 years of age: should patent foramen ovale be closed?
  8. 1068
    “…The soluble guanylate cyclase stimulator riociguat is licensed for the treatment of pulmonary arterial hypertension; here we present findings from patients who were receiving combined riociguat plus endothelin receptor antagonists or non-intravenous prostanoids in the randomized, placebo-controlled PATENT-1 study and its open-label extension (PATENT-2). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies)
  9. 1069
    “…The present study aims to determine the potential prophylactic effect of clopidogrel for migraine with patent foramen ovale (PFO) in patients who are poor responders to two or more common preventive medications. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clopidogrel can be an effective complementary prophylactic for drug-refractory migraine with patent foramen ovale
  10. 1070
    “…Persistent patent ductus arteriosus (PDA) is very common in preterm infants, especially in extremely preterm infants. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Transcatheter Closure of Patent Ductus Arteriosus in Infants With Weight Under 1,500 Grams
  11. 1071
    “…In order to assess the potential cardioembolic source an echocardiogram was performed, which revealed a large mass consistent with a thrombus in transit through a patent foramen ovale. Because of the high risk of systemic embolism, emergent surgical thrombectomy was performed with the intention to discharge the patient safely without any new embolic events. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Thrombus in transit through a patent foramen ovale: An unusual cause of cardiac embolism
  12. 1072
    “…Thrombus straddling a patent foramen ovale is a direct evidence of this scenario. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Thrombus straddling a patent foramen ovale and pulmonary embolism: A case report
  13. 1073
    “…This review aimed to map the existing patents of double-chamber syringes that can be used for intravenous drug administration and catheter flush. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Brief Report on Double-Chamber Syringes Patents and Implications for Infusion Therapy Safety and Efficiency
  14. 1074
    “…REPORT: The superficial femoral and popliteal artery containing a patent subintimal canal were explanted from a patient who died in the authors' ward. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Histological Analysis of a Long Term Patent Subintimal Canal in the Superficial Femoral Artery
  15. 1075
    “…OBJECTIVE: Systematic reviews suggest that patent foramen ovale closure (PFOc) is performed percutaneously with low complication rates. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Network meta-analysis on patent foramen ovale: is a stroke or atrial fibrillation worse?
  16. 1076
    “…This study aimed to assess the presence of the patent foramen ovale (PFO) in patients with the superior type of SVASD. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Presence of Patent Foramen Ovale in the Superior Type of Sinus Venosus Atrial Septal Defect
  17. 1077
    “…Background: The aim of this study was to describe our experience with transcatheter device closure of patent ductus arteriosus (PDA) in symptomatic low-birth-weight premature infants. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Transcatheter Closure of Patent Ductus Arteriosus in Premature Infants With Very Low Birth Weight
  18. 1078
    “…BACKGROUND: Minimally invasive transcatheter occlusion using Amplatz canine duct occluder (ACDO) is the treatment of choice for dogs with left‐to‐right shunting patent ductus arteriosus (PDA). However, in small dogs the femoral artery diameter is often too small to accommodate the guiding catheter required for ACDO deployment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Low profile vascular plug for transarterial occlusion of patent ductus arteriosus in small dogs
  19. 1079
    “…BACKGROUND: The introduction of generics after the loss of patent exclusivity plays a major role in budget savings by significantly decreasing drug prices. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Use of budget savings from patent expiration of cancer drugs to improve affordability and accessibility
  20. 1080
    “…The Jaccard similarity indices are computed based on a Natural Language Processing treatment of 69,923 patents in the pharmaceutical industry in China from 1990 to 2017.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Patent relatedness and velocity in the Chinese pharmaceutical industry: A dataset of Jaccard similarity indices
Herramientas de búsqueda: RSS